On Tuesday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Basic Energy Services, Inc. (NYSE:BAS), Twitter, Inc. (NYSE:TWTR), Arch Coal Inc. (NYSE:ACI), CytRx Corporation (NASDAQ:CYTR)
Basic Energy Services, Inc. (NYSE:BAS), with shares gained 6.48%, closed at $6.90.
Twitter, Inc. (NYSE:TWTR), with shares jumped 6.21%, settled at $51.47.
Arch Coal Inc. (NYSE:ACI), with shares climbed 6.05%, and closed at $1.03.
CytRx Corporation (NASDAQ:CYTR), surged 6.04%, and closed at $3.51.
Latest NEWS regarding these Stocks are depicted underneath:
Basic Energy Services, Inc. (NYSE:BAS)
Basic Energy Services, Inc. (BAS), declared that its administration will be presenting at the Scotia Howard Weil 43rd Annual Energy Conference to be held March 22 –26 in New Orleans.
Basic Energy Services, Inc. provides well site services to oil and natural gas drilling and producing companies in the United States. Its Completion and Remedial Services segment offers pumping services, such as cementing, acidizing, fracturing, nitrogen, and pressure testing; rental and fishing tools; coiled tubing; snubbing services; thru-tubing; cased-hole wireline services; and underbalanced drilling in low pressure and fluid sensitive reservoirs.
Twitter, Inc. (NYSE:TWTR)
In order to launch a new service that allows government officials to send tweets via SMS, Indian Prime Minister Narendra Modi has teamed up with Twitter, Inc. (TWTR), in a move to boost e-governance in the world’s largest democracy.
According to CNBC reports, The service called Twitter Samvad – which means dialogue in Hindi – was unveiled by CEO Dick Costolo and Modi late Tuesday in New Delhi and is part of the government’s Digital India program to transform the nation into a digitally empowered society.
Twitter, Inc. operates as a global platform for public self-expression and conversation in real time. It offers various products and services for users, counting Twitter that allows users to create, distribute, and discover content; and Vine and video, a mobile application that enables users to create and distribute short looping videos.
Arch Coal Inc. (NYSE:ACI)
According to Zacks Equity Research report, Arch Coal Inc. (ACI), is striving hard to cut costs to save its bottom line in this challenging coal environment. Arch Coal suspended its annual dividend to preserve financial flexibility. However, the projected Environmental Protection Agency (EPA) carbon plan, if implemented, will result in utility providers switching from coal to other alternate energy sources.
St. Louis, MO-based Arch Coal witnessed another lackluster quarter as a result of unfavorable weather patterns dampening domestic coal consumption. Arch Coal’s loss in the fourth quarter was wider than the Zacks Consensus Estimate while the top line marginally surpassed the mark.
Arch Coal presently carries a Zacks Rank #3 (Hold).
Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled about 5.1 billion tons of proven and probable recoverable reserves.
CytRx Corporation (NASDAQ:CYTR)
CytRx Corporation (CYTR), declared the appointment of Anita J. Chawla, PhD, to its Board of Directors, on March 11.
Dr. Chawla brings over 25 years of experience as an economist in the health care industry to CytRx, with a proven track record assisting pharmaceutical, biotechnology, medical device, and diagnostic companies achieve their product development and commercialization objectives. Most recently, she has offered planned consultancy services to a variety of life science companies, counting CytRx. With broad experience advising companies in matters counting corporate and business unit strategy, market dynamics across multiple therapeutic areas, reimbursement, health economics, and business analytics, her appointment strengthens the executive leadership team and adds noteworthy operational and commercial expertise.
Dr. Chawla presently serves as Managing Principal at Analysis Group, a consultancy firm that provides economic, financial, and business strategy consulting to corporations, law firms, and government agencies. Clients comprise major pharmaceutical manufacturers, biotech and medical device companies, counting smaller, innovative companies. Preceding to joining Analysis Group, she held positions at Genentech, Inc. as the head of the Health Economics & Outcomes Research department where she also supported the oncology franchise, The MEDSTAT Group (now Truven Health Analytics), and the American Medical Association (Center for Health Policy Research). She has over 75 professional presentations, technical reports, and publications to her credit. Dr. Chawla also serves on the Board of Trustees of Newbury College in Brookline, Massachusetts. She has served as a reviewer or referee for several journals, counting Value in Health, Health Affairs, Health Services Research, Journal of the American Medical Association, and Journal of Business and Economic Statistics. Dr. Chawla holds a Ph.D. in Economics from the University of Michigan and received a Bachelor of Arts degree in Economics and Political Science from Wellesley College.
CytRx Corporation operates as a biopharmaceutical research and development corporation specializing in oncology. The corporation’s product candidate comprises aldoxorubicin that has accomplished Phase IIb clinical trial as a first-line therapy for soft tissue sarcomas; and has initiated an international Phase II clinical trial in patients with late-stage glioblastoma multiforme, and a Phase II clinical trial in HIV-related Kaposi’s sarcoma.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
